Image

Mobility and Voiding Exercises in Older Women With Urinary Incontinence (MoVEonUp)

Recruiting
70 years of age
Female
Phase N/A

Powered by AI

Overview

A prospective, two-arm randomized clinical trial utilizing a multidimensional intervention to reduce falls in older women with Urinary Urge Incontinence. The intervention consist of general balance and strength training, bladder training and urge suppression, and home hazard assessments. The control group will receive informational booklets on fall prevention and behavioral treatment for urinary urge incontinence.

Eligibility

Inclusion Criteria:

  • Female
  • 70 or older
  • Living independently in the community
  • Willingness to be randomized.
  • Ability to read and understand English
  • Be able to provide informed consent
  • Low physical activity (physically active for 30 minutes or more less than or equal to 2 days per week on average over the past 6 months) per PAS
  • Ambulatory (defined as patient not confined to bed or wheelchair OR ability to walk with or without an assistive device)
  • Self-reported moderate to severe urge-predominant UI based on the ICIQ-SF > 6 (Q 1+2+3)
  • Not planning to initiate new UI or overactive bladder (OAB) treatment during the study duration
  • Capable of participation in an exercise program without exacerbating any pre-existing condition(s), as determined by their personal physician

Exclusion Criteria:

  • Unable to communicate in English
  • Non-ambulatory
  • Pelvic organ prolapse passed the hymen (per patient report)
  • Undergoing active treatment for cancer (other than non-melanoma skin cancer)
  • Uncorrected visual or hearing loss.
  • Other urinary conditions or procedures that may affect continence status for example: urethral diverticulum, previous augmentation cystoplasty
  • Progressive neurodegenerative disease e.g. Parkinson's disease, multiple sclerosis per patient report
  • History of stroke or carotid sensitivity (i.e. syncopal falls) per patient report
  • Unstable cardiac disease per patient report
  • Fracture or joint replacement within the last six months per patient report
  • Significant cognitive impairment (defined as a modified TICs score of < 27)
  • Not willing to sign Consent Form
  • ICIQ-SF < 6 (Q 1+2+3)
  • Primary care provider says no to enrollment

Study details

Urinary Incontinence, Urge

NCT05375344

University of Pennsylvania

26 January 2024

Step 1 Get in touch with the nearest study center
What happens next?
  • You can expect the study team to contact you via email or phone in the next few days.
  • Sign up as volunteer  to help accelerate the development of new treatments and to get notified about similar trials.

You are contacting

Investigator Avatar

Primary Contact

site

FAQs

Learn more about clinical trials

What is a clinical trial?

A clinical trial is a study designed to test specific interventions or treatments' effectiveness and safety, paving the way for new, innovative healthcare solutions.

Why should I take part in a clinical trial?

Participating in a clinical trial provides early access to potentially effective treatments and directly contributes to the healthcare advancements that benefit us all.

How long does a clinical trial take place?

The duration of clinical trials varies. Some trials last weeks, some years, depending on the phase and intention of the trial.

Do I get compensated for taking part in clinical trials?

Compensation varies per trial. Some offer payment or reimbursement for time and travel, while others may not.

How safe are clinical trials?

Clinical trials follow strict ethical guidelines and protocols to safeguard participants' health. They are closely monitored and safety reviewed regularly.
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.